Why the study?
The long-term prognosis of ST-elevation myocardial infarction patients referred back to their general practitioner after 1-year guideline-based treatment was unknown.
Does referral to a general practitioner after 1 year of guideline-based care result in good long-term prognosis in asymptomatic STEMI patients with LVEF >45%?
Does referral to a general practitioner after 1 year of guideline-based care result in good long-term prognosis in asymptomatic STEMI patients with LVEF >45%?
Answers are grounded in this paper and cite their sources.
Asymptomatic STEMI patients with preserved LVEF referred to primary care after 1 year of protocolized post-MI care have an excellent 5-year prognosis.
INTRODUCTION: Identifying ST-elevation myocardial infarction (STEMI) patients who can be referred back to the general practitioner (GP) can improve patient-tailored care. However, the long-term prognosis of patients who are returned to the care of their GP is unknown. Therefore, the aim of this study was to assess the long-term prognosis of patients referred back to the GP after treatment in accordance with a 1-year institutional guideline-based protocol. METHODS: All consecutive patients treated between February 2004 up to May 2013 who completed the 1‑year institutional MISSION! Myocardial Infarction (MI) follow-up and who were referred to the GP were evaluated. After 1 year of protocolised monitoring, asymptomatic patients with a left ventricular ejection fraction >45% on echocardiography were referred to the GP. Long-term prognosis was assessed with Kaplan-Meier curves and Cox proportional hazards analysis was used to identify independent predictors for 5‑year all-cause mortality and major adverse cardiovascular events (MACE). RESULTS: In total, 922 STEMI patients were included in this study. Mean age was 61.6 ± 11.7 years and 74.4% were male. Median follow-up duration after the 1‑year MISSION! MI follow-up was 4.55 years (interquartile range [IQR] 2.28-5.00). The event-free survival was 93.2%. After multivariable analysis, age, not using an angiotensin-converting enzyme (ACE) inhibitor/angiotensin-II (AT2) antagonist and impaired left ventricular function remained statistically significant predictors for 5‑year all-cause mortality. Kaplan-Meier curves revealed that 80.3% remained event-free for MACE after 5 years. Multivariable predictors for MACE were current smoking and a mitral regurgitation grade ≥2. CONCLUSION: STEMI patients who are referred back to their GP have an excellent prognosis after being treated according to the 1‑year institutional MISSION! MI protocol.
No takes yet. Share an insight, caveat, or question.
Bodde et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: